Medicines / Emcure Pharmaceuticals / Spegra
SpegraDolutegravir + Emtricitabine + Tenofovir Alafenamide
Spegra is marketed by Emcure Pharmaceuticals. 2 packs on NPPA's price list for July 2026, containing Dolutegravir + Emtricitabine + Tenofovir Alafenamide.
- Packs listed
- 2
- Lowest MRP
- ₹4,522
- Per unit
- ₹150.72
- Price-controlled packs
- 0 of 2
- Dosage forms
- 1
Packs and prices
- ₹4,522Spegra 50/200/25 mg Tablet 30Dolutegravir + Emtricitabine + Tenofovir Alafenamide Tablet 50/200/25 mg · ₹150.72 per tablet
- ₹13,564Spegra 50/200/25 mg Tablet 90Dolutegravir + Emtricitabine + Tenofovir Alafenamide Tablet 50/200/25 mg · ₹150.72 per tablet
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Dolutegravir + Emtricitabine + Tenofovir Alafenamide Tablet 50/200/25 mg
1 other brand of this composition on the price list; the 1 lowest per tablet are shown. All Dolutegravir + Emtricitabine + Tenofovir Alafenamide packs
The company
Emcure Pharmaceuticals has 1,373 packs on the price list, and CDSCO has named it as the manufacturer of 4 failed batches since Mar 2019. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.